美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Veradermics, Inc.

74.12

-6.3800-7.93%

盤後：74.130.0100+0.01%16:50 EDT

成交量：51.94萬

成交額：3,910.99萬

市值：27.68億

市盈率：-33.19

高：80.90

開：80.90

低：72.48

收：80.50

52周最高：80.90

52周最低：32.00

股本：3,733.87萬

流通股本：1,745.99萬

量比：1.05

換手率：2.98%

股息：- -

股息率：- -

每股收益(TTM):-2.2330

每股收益(LYR):-111.9114

淨資產收益率：-72.06%

總資產收益率：-43.45%

市淨率：-22.53

市盈率(LYR):-0.66

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

旗艦企業 Generate Biomedicines 希望在美國 IPO 中獲得 22 億美元估值

植髮藥物開發商Veradermics(MANE.US)IPO定價17美元/股上市首日暴漲122%

異動解讀 | Veradermics紐交所IPO首秀盤中暴漲134.35%，禮來入股意向與脱髮治療前景引爆市場

BUZZ-Veradermics 紐交所首秀股價大漲，擴大規模IPO募資2.563億美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MANE"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MANE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","market":"US","secType":"STK","nameCN":"Veradermics, Inc.","latestPrice":74.12,"timestamp":1776369600000,"preClose":80.5,"halted":0,"volume":519437,"hourTrading":{"tag":"盘后","latestPrice":74.13,"preClose":74.12,"latestTime":"16:50 EDT","volume":1676,"amount":124225.6228,"timestamp":1776372603097,"change":0.01,"changeRate":0.000135,"amplitude":0.000135},"delay":0,"changeRate":-0.07925465838509312,"floatShares":17459900,"shares":37338700,"eps":-2.233,"marketStatus":"盤後交易","change":-6.38,"latestTime":"04-16 19:30:26 EDT","open":80.9,"high":80.9,"low":72.48,"amount":39109850.57049,"amplitude":0.104596,"askPrice":75.57,"askSize":26,"bidPrice":74.13,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-2.233,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1776384000000},"marketStatusCode":4,"adr":0,"listingDate":1770181200000,"exchange":"NYSE","adjPreClose":80.5,"preHourTrading":{"tag":"盘前","latestPrice":83,"preClose":80.5,"latestTime":"09:13 EDT","volume":442,"amount":36282.175540000004,"timestamp":1776345181452,"change":2.5,"changeRate":0.031056,"amplitude":0.048447},"postHourTrading":{"tag":"盘后","latestPrice":74.13,"preClose":74.12,"latestTime":"16:50 EDT","volume":1676,"amount":124225.6228,"timestamp":1776372603097,"change":0.01,"changeRate":0.000135,"amplitude":0.000135},"volumeRatio":1.052142},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","floatShares":17459900,"roa":"-43.45%","roe":"-72.06%","lyrEps":-111.911419,"volumeRatio":1.052142,"shares":37338700,"dividePrice":0,"high":80.9,"amplitude":0.104596,"preClose":80.5,"low":72.48,"week52Low":32,"pbRate":"-22.53","week52High":80.9,"institutionHeld":0,"latestPrice":74.12,"committee":-0.793103,"eps":-2.233,"divideRate":0,"volume":519437,"delay":0,"ttmEps":-2.233,"open":80.9,"prevYearClose":17,"prevWeekClose":68.8,"prevMonthClose":63.15,"prevQuarterClose":63.15,"fiveDayClose":59.98,"twentyDayClose":59.01,"sixtyDayClose":17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MANE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MANE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MANE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0.25,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1772769600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MANE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MANE","date":"2026-04-15","current":-33.193014,"percent":0.163265,"low":-46.874652,"twenty":-39.496838,"median":-33.204324,"eighty":-30.234102,"high":-9.296992,"avg":-33.433456,"sd":7.082769,"marketCap":2800148347},"quantilePoints":[{"date":"2026-02-06","current":-25.786263,"twenty":-25.079893,"median":-17.8457,"eighty":-10.368249,"marketCap":1387507243},{"date":"2026-02-13","current":-30.838039,"twenty":-29.065754,"median":-25.786263,"eighty":-19.198356,"marketCap":1659333205},{"date":"2026-02-20","current":-33.530469,"twenty":-32.062123,"median":-28.069277,"eighty":-25.043809,"marketCap":1804207481},{"date":"2026-02-27","current":-29.776333,"twenty":-31.085076,"median":-29.967163,"eighty":-25.732137,"marketCap":1602204947},{"date":"2026-03-06","current":-33.738647,"twenty":-32.654736,"median":-30.560469,"eighty":-26.152655,"marketCap":1815409101},{"date":"2026-03-13","current":-35.785726,"twenty":-33.721993,"median":-31.049686,"eighty":-27.249057,"marketCap":1925558357},{"date":"2026-03-20","current":-39.491287,"twenty":-35.53175,"median":-31.816474,"eighty":-28.546698,"marketCap":2124947181},{"date":"2026-03-27","current":-46.874652,"twenty":-39.507941,"median":-32.867771,"eighty":-29.468231,"marketCap":2522231279},{"date":"2026-04-02","current":-31.356106,"twenty":-39.513493,"median":-32.867771,"eighty":-29.852665,"marketCap":2194770608},{"date":"2026-04-10","current":-31.99758,"twenty":-38.92088,"median":-32.857362,"eighty":-30.17702,"marketCap":2239670594},{"date":"2026-04-15","current":-40.004977,"twenty":-39.496838,"median":-33.204324,"eighty":-30.234102,"marketCap":2800148347}],"updateTime":1776378652516},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MANE\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613789435","title":"旗艦企業 Generate Biomedicines 希望在美國 IPO 中獲得 22 億美元估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2613789435","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613789435?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 19:54","pubTimestamp":1771847674,"startTime":"0","endTime":"0","summary":"更新版 3-旗舰企业 Generate Biomedicines 希望在美国 IPO 中获得 22 亿美元估值在第 3、6、7 段添加分析师评论Arasu Kannagi Basil路透2月23日 - 药物开发商Generate Biomedicines周一表示，该公司在美国首次公开募股的目标估值将高达21.7亿美元，从而进入上市步伐加快的生物技术市场。Aktis Oncology AKTS.O、Agomab Therapeutics AGMB.O、Veradermics MANE.N、Eikon Therapeutics EIKN.O和SpyGlass Pharma SGP.O今年已经登陆美国资本市场。\"Generate公司用于治疗严重哮喘的主要候选产品GB-0895正在进行后期试验。预计这项研究将于 2028 年上半年全部完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL4S3ZJ0Q2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","LU0122379950.USD","AKTS","IE0004091025.USD","MRNY","MRNX","MANE","LU0098860793.USD","LU0234570918.USD","BK4532","LU0889565916.HKD","LU1162221912.USD","BK4516","LU0251142724.SGD","BK4552","LU1244550494.USD","IE00B2B36J28.USD","LU0912757837.SGD","LU1868836757.USD","EIKN","LU0096364046.USD","LU1791807156.HKD","LU2028103732.USD","LU2111349929.HKD","SGP","LU2750360997.AUD","BK4139","LU2471134796.USD","MRNA","BK4550","GSX","LU1868836914.USD","BK4534","IE00BJJMRZ35.SGD","LU0795875169.SGD","LU0106261372.USD","BK4127","LU0320765992.SGD","LU2237443465.HKD","IE0009355771.USD","LU2265009873.SGD","LU2750360641.GBP","LU2089283258.USD","LU2133065610.SGD","IE00BKVL7J92.USD","LU1804176565.USD","LU2237443622.USD","BK4566","PIPR","AGMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609634894","title":"植髮藥物開發商Veradermics(MANE.US)IPO定價17美元/股 上市首日暴漲122%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609634894","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609634894?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 09:18","pubTimestamp":1770254331,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，植发药物开发商Veradermics上市首日收涨逾122%，报37.75美元，远高于其首次公开募股的发行价17美元。该公司在IPO中筹集了2.563亿美元。知情人士称，此次扩大发行规模后的IPO获得了数倍于发行量的超额认购。根据申报文件，Wellington Management曾表示有意按照IPO价格认购最多3000万美元的股份。据悉，Veradermics正在研发一种适用于男女性雄激素性脱发的口服非激素疗法。数据显示，Veradermics 在截至去年9月30日的九个月内净亏损为4810万美元，而上年同期的净亏损为2080万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"植发药物开发商Veradermics(MANE.US)IPO定价17美元/股 上市首日暴涨122%","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105726922","title":"異動解讀 | Veradermics紐交所IPO首秀盤中暴漲134.35%，禮來入股意向與脱髮治療前景引爆市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1105726922","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105726922?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 03:25","pubTimestamp":1770233134,"startTime":"0","endTime":"0","summary":"Veradermics, Inc.今日盘中股价大幅飙升134.35%，市场表现异常强劲。此次股价暴涨与公司今日在纽约证券交易所的首次公开募股首秀密切相关。MANE本次IPO规模较原计划有所扩大，以每股17美元的价格发行了1,510万股，共募集资金2.563亿美元。此外，制药巨头礼来公司已表示有意购买此次IPO中最多4.9%的股票，这一重要背书显著提振了市场信心。Veradermics专注于开发针对脱发的治疗方法，其市场前景广阔。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609397389","title":"BUZZ-Veradermics 紐交所首秀股價大漲，擴大規模IPO募資2.563億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609397389","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609397389?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 03:12","pubTimestamp":1770232375,"startTime":"0","endTime":"0","summary":"BUZZ-Veradermics 纽交所首秀股价大涨，扩大规模IPO募资2.563亿美元2月4日 - ** 头发修复药物开发商VeradermicsMANE.N的股票在纽约证券交易所首次上市时上涨了一倍多** 股票以 34 美元开盘，最高上涨到 40 美元；最后上涨 126.5%，收于 38.5 美元** MANE 在规模扩大的首次公开募股中以每股 17 美元的价格出售了 1,510 万股  股票，募集资金 2.563 亿美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nL4T3Z02BK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0097036916.USD","LU0122379950.USD","LU0943347566.SGD","BK4588","SG9999015986.USD","IE00BK4W5L77.USD","LU1668664300.SGD","LU0385154629.USD","LU2237443622.USD","LU2089283258.USD","LU2108987350.USD","IE0004445239.USD","SG9999015945.SGD","LU0456855351.SGD","LU2168564149.EUR","IE00BJJMRX11.SGD","SG9999014906.USD","LU0289739699.SGD","LU1244550577.SGD","LU0238689110.USD","LU0079474960.USD","LU1201861249.SGD","LU1868837300.USD","LU0320765992.SGD","LU0158827781.USD","LU0471298694.HKD","LU1035775433.USD","LU1323610961.USD","LU2552382058.USD","LU1093756168.USD","LU2360032135.SGD","LU0106831901.USD","LU0158827948.USD","LU1267930227.SGD","LU1988902786.USD","LU0210536198.USD","LU1814569148.SGD","LU2361044865.SGD","LU0320765059.SGD","LU1057294990.SGD","LU2602419157.SGD","LU2361044949.HKD","LU2168564495.EUR","LU0477156953.USD","LU2063271972.USD","LU0882574055.USD","LU0889565916.HKD","LU0130102774.USD","LU2461242641.AUD","LU0061475181.USD","SGXZ81514606.USD","LU1232071149.USD","LU2125154778.USD","LU2112291526.USD","IE0004445015.USD","IE00B4JS1V06.HKD","LU0234572021.USD","LU2089284900.SGD","IE00B2B36J28.USD","LU2746668461.USD","LU1989771016.USD","BK4534","LU2106854487.HKD","LU1061106388.HKD","LU0689472784.USD","LU1868836757.USD","LU2168564065.EUR","LU2237443465.HKD","LU1791807156.HKD","SG9999015978.USD","BK4599","LU0354030438.USD","LU0823434740.USD","MANE","LU1712237335.SGD","LU2023251221.USD","LU0109391861.USD","LU0786609619.USD","IE00B1BXHZ80.USD","LU2750360997.AUD","LU0266013472.USD","LU2237443382.USD","LU1162221912.USD","LU0820561909.HKD","BK4007","LU1244550494.USD","SGXZ31699556.SGD","LU0820561818.USD","LU1868836591.USD","LU0882574139.USD","LU2456880835.USD","SGXZ99366536.SGD","LU2471134523.USD","IE00BSNM7G36.USD","LU0058720904.USD","IE00BWXC8680.SGD","IE00BFTCPJ56.SGD","BK4516","LU0094547139.USD","LU0096364046.USD","IE00B1XK9C88.USD","LU2125154935.USD","LU2491050154.USD","LU2111349929.HKD","LU2357305700.SGD","LU1280957306.USD","LU1267930730.SGD","LU1366192091.USD","LU2087625088.SGD","LU2237438978.USD","LU0708995401.HKD","IE0005OL40V9.USD","SG9999014898.SGD","LU1244550221.USD","SG9999013999.USD","LU0980610538.SGD","LU0203202063.USD","LU0098860793.USD","LU0787776722.HKD","LU0354030511.USD","LU0314106906.USD","LU0225283273.USD","LU2089984988.USD","LU1127390331.HKD","LU0417517546.SGD","LU1868836914.USD","LU1868837136.USD","LU0106261372.USD","LU1551013342.USD","BK4504","LU0323591593.USD","LU2237443895.HKD","IE0002141913.USD","LU0672654240.SGD","LU0310800965.SGD","LU1917777945.USD","LU0640476718.USD","LU1623119135.USD","GB00BDT5M118.USD","LU0320765646.SGD","SGXZ57979304.SGD","LU0648001328.SGD","IE00BJLML261.HKD","LU2168563687.JPY","LU1506573853.SGD","IE00BN29S564.USD","LU1093756325.SGD","LU1720051108.HKD","LU2324357040.USD","SG9999015952.SGD","LU0128525689.USD","LU2211815571.USD","LU2462157665.USD","LU2237443549.SGD","LU0683600562.USD","LU1983299246.USD","LU0432979614.USD","IE0009355771.USD","LU0130517989.USD","IE00B775H168.HKD","LU1551013425.SGD","SG9999018857.SGD","IE00BKDWB100.SGD","SGXZ51526630.SGD","BK4585","LU2896262040.SGD","IE00BJJMRY28.SGD","LU0353189680.USD","SG9999017495.SGD","LU2271345857.HKD","LU1291159041.SGD","LU2491050071.SGD","IE00B4R5TH58.HKD","LU0114720955.EUR","IE00BFSS7M15.SGD","LU2023250504.SGD","LU1720051017.SGD","IE00BJJMRZ35.SGD","LU0471298777.SGD","LU2471134879.HKD","LU0466842654.USD","LU2265009873.SGD","LU2552382215.SGD","LU0823416689.USD","SG9999001176.SGD","LU2360106947.USD","IE00BFSS8Q28.SGD","LU1023059063.AUD","LU2491049909.HKD","BK4581","IE00BKPKM429.USD","LU0109394709.USD","BK4566","LU1064131342.USD","LU2236285917.USD","SG9999001176.USD","LU2417539215.USD","LU0256863811.USD","LU1548497426.USD","LU2361045086.USD","LU0006306889.USD","LU2168564222.USD","LU0316494557.USD","LU2264538146.SGD","LU1974910355.USD","SG9999018865.SGD","BK4559","IE00B7KXQ091.USD","LU2028103732.USD","LU2237443978.SGD","LU0162691827.USD","LU0353189763.USD","LU0072461881.USD","LU0823434583.USD","LU1069344957.HKD","SG9999014914.USD","BK4533","LU0170899867.USD","LU0198837287.USD","LU1804176565.USD","LU2750360641.GBP","LU2471134952.CNY","LU2552382132.HKD","LU2468319806.SGD","LU0256863902.USD","IE00BK4W5M84.HKD","IE00BJT1NW94.SGD","LU2471134796.USD","SG9999014880.SGD","LU0203201768.USD","BK4207","LU0052756011.USD","LU2746668974.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MANE\",params:#limit:6,delay:false,,,undefined,":[]}}